top of page
.png)
Onco-Summaries: Daily Oncology Updates at a Glance
04/08/2025 Alphamab's IND application for JSKN022 was accepted by China's CDE ( Ref ) Alphamab Oncology's IND application for JSKN022...
Oncofocus Team
Aug 4, 20252 min read
Onco-Summaries: Daily Oncology Updates at a Glance
30/07/2025 Phase 3 COSTAR Lung trial of dostarlimab + docetaxel ± cobolimab failed to meet the OS endpoint in previously treated NSCLC (...
Oncofocus Team
Jul 31, 20251 min read
bottom of page